¼¼°èÀÇ ÇÁ·Î¹ÙÀÌ¿Àƽ½º °­È­ À¯Á¦Ç° ´ëüǰ ½ÃÀå ¿¹Ãø(-2032³â) : Á¦Ç°, ±ÕÁÖ À¯Çü, °ø±Þ¿ø, ¿ëµµ, ÃÖÁ¾»ç¿ëÀÚ, Áö¿ªº° ¼¼°è ºÐ¼®
Probiotic-Enriched Dairy Alternatives Market Forecasts to 2032 - Global Analysis By Product (Plant-Based Yogurts, Probiotic Milks, Cheeses, Kefir and Other Products), Strain Type, Source, Application, End User and By Geography
»óǰÄÚµå : 1822392
¸®¼­Ä¡»ç : Stratistics Market Research Consulting
¹ßÇàÀÏ : 2025³â 09¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 200+ Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 4,150 £Ü 5,880,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 5,250 £Ü 7,439,000
PDF (2-5 User License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ »ç¾÷Àå¿¡¼­ 5¸í±îÁö ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â 5ȸ±îÁö °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 6,350 £Ü 8,998,000
PDF & Excel (Site License) help
PDF ¹× Excel º¸°í¼­¸¦ µ¿ÀÏ »ç¾÷ÀåÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â 5ȸ±îÁö °¡´ÉÇÕ´Ï´Ù. Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ¹× Excel ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 7,500 £Ü 10,628,000
PDF & Excel (Global Site License) help
PDF ¹× Excel º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â 10ȸ±îÁö °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


Çѱ۸ñÂ÷

Stratistics MRC¿¡ µû¸£¸é ¼¼°èÀÇ ÇÁ·Î¹ÙÀÌ¿Àƽ½º °­È­ À¯Á¦Ç° ´ëüǰ ½ÃÀåÀº 2025³â¿¡ 37¾ï ´Þ·¯¸¦ Â÷ÁöÇÏ¸ç ¿¹Ãø ±â°£ Áß CAGR 11.2%·Î ¼ºÀåÇϸç, 2032³â¿¡´Â 79¾ï ´Þ·¯¿¡ ´ÞÇÒ Àü¸ÁÀÔ´Ï´Ù.

ÇÁ·Î¹ÙÀÌ¿Àƽ½º °­È­ À¯Á¦Ç° ´ëüǰÀº »ì¾ÆÀÖ´Â ÇÁ·Î¹ÙÀÌ¿Àƽ½º ¹è¾ç±ÕÀÌ ÁÖÀÔµÈ ¾Æ¸óµå, µÎÀ¯, ¿ÀÆ®¹Ð ¿ìÀ¯, ¿ä°ÅÆ®, Ä¡Áî¿Í °°Àº ½Ä¹°¼º Á¦Ç°ÀÔ´Ï´Ù. ÀÌ À¯ÀÍÇÑ ¹ÚÅ׸®¾Æ´Â Àå °Ç°­, ¼ÒÈ­ ¹× ¸é¿ª·ÂÀ» Áö¿øÇÕ´Ï´Ù. À¯Á¦Ç°À» ÇÇÇÏ´Â »ç¶÷µéÀ» À§ÇØ ¸¸µé¾îÁø ÀÌ ´ëü ½ÄǰÀº Å©¸² °°Àº ½Ä°¨°ú dz¹Ì¸¦ Á¦°øÇÏ´Â µ¿½Ã¿¡ °Ç°­»ó ÀÌÁ¡À» Á¦°øÇÕ´Ï´Ù. À½·á, ¿ä°ÅÆ®, ½ºÇÁ·¹µå ÇüÅ·ΠÁ¦°øµÇ´Â ÀÌ Á¦Ç°µéÀº ½Ä¹°¼º ¼ººÐ°ú ÇÁ·Î¹ÙÀÌ¿Àƽ½º¸¦ °áÇÕÇÏ¿© °Ç°­°ú ¼ÒÈ­¸¦ µ½´Â ºñ°Ç, ¶ôÅä¿À½º ÇÁ¸® ¿É¼ÇÀ» ã´Â ¼ÒºñÀÚµéÀ» À§ÇÑ Á¦Ç°ÀÔ´Ï´Ù.

¹ÎÅÚ¿¡ µû¸£¸é ½Ä¹°¼º ¿ä°ÅÆ® ¹× À½·á´Â ¼ÒÈ­±â °Ç°­À» Áö¿øÇϱâ À§ÇØ »ì¾ÆÀÖ´Â ¹è¾ç±ÕÀ» °­È­ÇÏ´Â °æÇâÀÌ Áõ°¡Çϰí ÀÖÀ¸¸ç, À¯Á¦Ç°À» »ç¿ëÇÏÁö ¾Ê´Â °Í°ú ÇÁ·Î¹ÙÀÌ¿Àƽ½ºÀÇ µ¿ÇâÀ» °áÇÕÇϰí ÀÖ´Ù°í ÇÕ´Ï´Ù.

Àå °Ç°­¿¡ ´ëÇÑ ¼ö¿ä

±× ÁÖ¿ä ¿äÀÎÀº Àå³» ¹Ì»ý¹°ÀÌ °Ç°­ Àü¹Ý¿¡ ¹ÌÄ¡´Â Áß¿äÇÑ ¿ªÇÒ¿¡ ´ëÇÑ ¼ÒºñÀÚÀÇ ÀνÄÀÌ ³ô¾ÆÁö¸é¼­ ¼ÒÈ­»Ó¸¸ ¾Æ´Ï¶ó ¸é¿ª·Â, Á¤½Å°Ç°­±îÁö ¿µÇâÀ» ¹ÌÄ¡°í Àֱ⠶§¹®ÀÔ´Ï´Ù. ÀÌ¿¡ µû¶ó È¿°ú°¡ ÀÔÁõµÈ ±â´É¼º ½Äǰ¿¡ ´ëÇÑ Àû±ØÀûÀÎ ¼ö¿ä°¡ ¹ß»ýÇϰí ÀÖ½À´Ï´Ù. ÇÁ·Î¹ÙÀÌ¿Àƽ½º·Î °­È­µÈ À¯Á¦Ç° ´ëüǰÀº ÀÌ·¯ÇÑ °Ç°­ µ¿Çâ°ú ÇÔ²² ¶°¿À¸£´Â ½Ä¹°¼º ½Ä´Ü°ú ¿Ïº®ÇÏ°Ô °áÇÕÇÏ¿© µÎ °¡Áö ÀÌÁ¡À» Á¦°øÇÕ´Ï´Ù. Áï, À¯´çºÒ³»Áõ, ä½ÄÁÖÀÇÀÚ, Ç÷º½ÃÅ׸®¾ð µîÀÇ ¼ÒºñÀÚ¸¦ ¹è·ÁÇÏ´Â µ¿½Ã¿¡ ¼ÒÈ­±â °Ç°­À» Àû±ØÀûÀ¸·Î Áö¿øÇÏ´Â °ÍÀÔ´Ï´Ù.

±ÕÁÖ¿¡ ´ëÇÑ ±ÔÁ¦ À庮

ÇÁ·Î¹ÙÀÌ¿Àƽ½º ±ÕÁÖ Å¬·¹ÀÓ¿¡ ´ëÇÑ ±ÔÁ¦ »óȲÀº Àü ¼¼°è¿¡¼­ º¹ÀâÇÏ°í ´Ù¾çÇÏ´Ù´Â Á¡ÀÌ Å« °É¸²µ¹·Î ÀÛ¿ëÇϰí ÀÖ½À´Ï´Ù. ij³ª´Ù º¸°ÇºÎ(Health Canada), À¯·´ ½ÄǰÀǾ౹(EFSA), ¹Ì±¹ ½ÄǰÀǾ౹(FDA)Àº '¸é¿ª·Â °­È­', '¼ÒÈ­±â °Ç°­ °³¼±' µî ƯÁ¤ °Ç°­ È¿°ú¸¦ ÀÔÁõÇϱâ À§ÇØ °¢±â ´Ù¸¥ ±î´Ù·Î¿î ¿ä°ÇÀ» Àû¿ëÇϰí ÀÖ½À´Ï´Ù. ÀÌ´Â Á¦Á¶¾÷ü¿¡°Ô ºñ¿ë°ú ½Ã°£ÀÌ ¸¹ÀÌ ¼Ò¿äµÇ´Â À庮ÀÌ µÇ¾î ±â¼ú Çõ½Å°ú ½ÃÀå ÁøÀÔÀ» Á¦ÇÑÇÕ´Ï´Ù. ¶ÇÇÑ ÆÐŰÁö¿¡ ¸íÈ®ÇÑ È¿´É-È¿°ú¸¦ Ç¥½ÃÇÏÁö ¸øÇÏ¸é ¼ÒºñÀÚ ±³À°¿¡ ¹æÇذ¡ µÇ°í, ¼ÒºñÀÚ°¡ Á¦Ç°ÀÇ °¡Ä¡ Á¦¾ÈÀ» ÀÌÇØÇÏÁö ¸øÇØ ½ÃÀå ¼ºÀåÀ» ÀúÇØÇÒ ¼ö ÀÖ½À´Ï´Ù.

¹Ý·Áµ¿¹°¿ë ÇÁ·Î¹ÙÀÌ¿Àƽ½º ½ÃÀåÀÇ ¼ºÀå¼¼

¹Ý·Áµ¿¹°ÀÇ Àΰ£È­¿Í ¹Ý·Áµ¿¹°ÀÇ °Ç°­ µ¿ÇâÀ» µ¿¹°¿¡°Ô±îÁö È®´ëÇϰíÀÚ ÇÏ´Â º¸È£ÀÚµéÀÇ ¿­¸ÁÀ¸·Î ¹Ý·Áµ¿¹°¿ë ÇÁ·Î¹ÙÀÌ¿Àƽ½º ºÐ¾ß´Â ±Þ¼ºÀåÇÒ ¼ö ÀÖ´Â ±âȸ°¡ Á¸ÀçÇÕ´Ï´Ù. ½Ä¹°¼º ÇÁ·Î¹ÙÀÌ¿Àƽ½º º¸ÃæÁ¦³ª °£½ÄÀº ¹Ý·Áµ¿¹°ÀÇ À½½Ä ¾Ë·¹¸£±â³ª ¼ÒÈ­±â Áúȯ, µ¿¹°ÀÇ °Ç°­ Àü¹Ý¿¡ ´ëÇÑ °ü½ÉÀÌ ³ô¾ÆÁü¿¡ µû¶ó ¹Ý·Áµ¿¹°ÀÇ °Ç°­¿¡ ´ëÇÑ °ü½ÉÀÌ ³ô¾ÆÁø °Í¿¡ ´ëÇÑ ´ëÀÀÃ¥ÀÔ´Ï´Ù. ÀÌ Æ´»õ ½ÃÀåÀº Àΰ£¿ë Á¦Ç°º¸´Ù Æ÷È­µµ°¡ ³·°í ÇÁ¸®¹Ì¾öÈ­ °¡´É¼ºÀÌ ³ô±â ¶§¹®¿¡ ÇÙ½É ¼ÒºñÀÚÃþ»Ó¸¸ ¾Æ´Ï¶ó ¼öÀͼºÀÌ ³ôÀº ¾Ö¿Ïµ¿¹° ÄÉ¾î »ê¾÷À¸·Î È®ÀåÇÒ ¼ö ÀÖ´Â ±æÀ» ¿­¾îÁÖ°í ÀÖ½À´Ï´Ù.

ÇÁ¸®¹Ì¾ö °¡°ÝÀÌ º¸±ÞÀ» ´ÊÃä´Ï´Ù.

ÁÖ¿ä ½ÃÀå À§ÇùÀº À̵é Á¦Ç°ÀÇ ÇÁ¸®¹Ì¾ö °¡°ÝÀ̸ç, ±âÁ¸ À¯Á¦Ç°À̳ª ³óÃàµÇÁö ¾ÊÀº ½Ä¹°¼º ´ëüǰº¸´Ù ÈξÀ ´õ ³ôÀº °æ¿ì°¡ ¸¹½À´Ï´Ù. ÀÌ ºñ¿ëÀº °í°¡ÀÇ ÇÁ·Î¹ÙÀÌ¿Àƽ½º ±ÕÁÖ, º¹ÀâÇÑ ¹ßÈ¿ °úÁ¤, ǰÁú ÀÎÁõ¿¡ µû¸¥ °ÍÀÔ´Ï´Ù. °¡°Ý¿¡ ¹Î°¨ÇÑ ¼ÒºñÀÚ¿¡°Ô´Â ÀÌ·¯ÇÑ °í°¡¼ºÀÌ ½Ã¿ë ¹× Á¤±âÀûÀΠäÅÿ¡ Å« À庮ÀÌ µÇ¾î ½ÃÀåÀ» °Ç°­ ÁöÇâÀûÀÎ °í¼ÒµæÃþÀ¸·Î Á¦ÇÑÇϰí, ÁÖ·ù¿¡ ³Î¸® ¹Þ¾Æµé¿©Á® ÆÇ¸Å·® Áõ°¡¸¦ µÐÈ­½Ãų ¼ö ÀÖ½À´Ï´Ù.

COVID-19ÀÇ ¿µÇâ:

COVID-19 ÆÒµ¥¹ÍÀº ¼ø±â´ÉÀ¸·Î ÀÛ¿ëÇÏ¿© ¼ö¿ä¸¦ ±Þ°ÝÈ÷ Áõ°¡½ÃÄ×½À´Ï´Ù. ¸é¿ª·Â °­È­¿¡ ´ëÇÑ ¼ÒºñÀÚµéÀÇ ³ôÀº °ü½ÉÀº È¿´ÉÀÌ ÀÔÁõµÈ ±â´É¼º ½Äǰ¿¡ ´ëÇÑ °ü½ÉÀÌ ±ÞÁõÇϸ鼭 ÇÁ·Î¹ÙÀÌ¿Àƽ½º Á¦Ç°¿¡ Á÷Á¢ÀûÀÎ ¼öÇý¸¦ °¡Á®´ÙÁÖ¾ú½À´Ï´Ù. Ãʱ⠰ø±Þ¸ÁÀÇ È¥¶õÀº ÀϽÃÀûÀΠǰ±ÍÇö»óÀ» ÃÊ·¡ÇßÀ¸³ª, Àå±âÀûÀÎ È¿°ú´Â ¼ÒºñÀÚÃþÀÇ Áö¼ÓÀûÀÎ È®´ë¿´½À´Ï´Ù. Áý¿¡¼­µµ °Ç°­À» ì±â·Á´Â ¸¹Àº ù ±¸¸ÅÀÚµéÀÌ ÀÌ Á¦Ç°µéÀ» ½ÃµµÇغ¸°í, ÀÌÈÄ¿¡µµ ²ÙÁØÈ÷ ½Ä»ýȰ¿¡ Àû¿ëÇϰí ÀÖ½À´Ï´Ù.

¿¹Ãø ±â°£ Áß ½Ä¹°¼º ¿ä±¸¸£Æ® ºÎ¹®ÀÌ °¡Àå Å« ½ÃÀåÀ¸·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

½Ä¹°¼º ¿ä±¸¸£Æ® ºÎ¹®Àº ¿¹Ãø ±â°£ Áß °¡Àå Å« ½ÃÀå Á¡À¯À²À» Â÷ÁöÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ½Ä¹°¼º ¿ä±¸¸£Æ®´Â ±âÁ¸ À¯Á¦Ç° ¿ä±¸¸£Æ®ÀÇ ½Ä°¨, ½Å¸À, ¼Òºñ °æÇèÀ» Àß ¸ð¹æÇϰí ÀÖ½À´Ï´Ù. ¾Æ¸óµå, ±Í¸®, ÄÚÄÚ³Ó°ú °°Àº ±âº» ¼ººÐÀÇ Çõ½ÅÀ¸·Î ¸À°ú ½Ä°¨ÀÌ È¹±âÀûÀ¸·Î °³¼±µÇ¾î À¯´çºÒ³»Áõ, ä½ÄÁÖÀÇÀÚ, Àå °Ç°­ È¿°ú¸¦ ¿øÇÏ´Â ¼ÒºñÀڵ鿡°Ô ¼±È£µÇ´Â ¼±ÅÃÀÌ µÇ°í ÀÖ½À´Ï´Ù.

À¯»ê±Õ ºÎ¹®Àº ¿¹Ãø ±â°£ Áß °¡Àå ³ôÀº CAGRÀ» º¸ÀÏ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

¿¹Ãø ±â°£ Áß À¯»ê±Õ ºÎ¹®Àº ƯÈ÷ ¼ÒÈ­±â °Ç°­ ¹× ¸é¿ª Áö¿ø°ú °°ÀÌ Àß ¹®¼­È­µÇ°í ³Î¸® ¾Ë·ÁÁø °Ç°­»ó ÀÌÁ¡¿¡ ÈûÀÔ¾î °¡Àå ³ôÀº ¼ºÀå·üÀ» º¸ÀÏ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ÀÌ´Â ¼ÒºñÀÚµé »çÀÌ¿¡¼­ °¡Àå ¸¹ÀÌ ¿¬±¸µÇ°í ½Å·Ú¹Þ´Â ÇÁ·Î¹ÙÀÌ¿Àƽ½º ¼Ó Áß ÇϳªÀÔ´Ï´Ù. Á¦Á¶¾÷üµéÀº À¯»ê±ÕÀÇ È¿´É, ¾ÈÁ¤¼º, Ä£¼÷ÇÔ ¶§¹®¿¡ ¹ßÈ¿ ¹× ³óÃà¿¡ À¯»ê±ÕÀ» ¼±È£Çϰí ÀÖÀ¸¸ç, ´Ù¾çÇÑ ½ÅÁ¦Ç° Á¦Á¶¿¡ ºü¸£°Ô äÅÃÇϰí ÀÖ½À´Ï´Ù.

°¡Àå Å« Á¡À¯À²À» Â÷ÁöÇÏ´Â Áö¿ª:

¿¹Ãø ±â°£ Áß ¾Æ½Ã¾ÆÅÂÆò¾çÀÌ °¡Àå Å« ½ÃÀå Á¡À¯À²À» Â÷ÁöÇÒ °ÍÀ¸·Î ¿¹»óµÇ´Âµ¥, ÀÌ´Â À¯´ç ºÒ³»ÁõÀÇ ³ôÀº À¯º´·ü, ½Ä¹°¼º ¹ßÈ¿ ½Äǰ(¿¹: Äá ±â¹Ý)À» ¼·ÃëÇÏ´Â ¿À·£ ¹®È­Àû ÀüÅë ¹× ´ë±Ô¸ð ¼ÒºñÀÚ ±â¹Ý¿¡ ±âÀÎÇÕ´Ï´Ù. °¡Ã³ºÐ ¼Òµæ Áõ°¡, ÆÒµ¥¹Í ÀÌÈÄ ³ô¾ÆÁø °Ç°­ ÀνÄ, ÇÕ¸®ÀûÀÎ °¡°ÝÀÇ ±¹³»¿Ü ºê·£µå°¡ ³Î¸® º¸±ÞµÇ¸é¼­ ÀÌ ½ÃÀå¿¡¼­ ÀÌ Áö¿ªÀÇ ¸®´õ½ÊÀ» È®°íÈ÷ Çϰí ÀÖ½À´Ï´Ù.

CAGRÀÌ °¡Àå ³ôÀº Áö¿ª:

¿¹Ãø ±â°£ Áß ºÏ¹Ì´Â ä½ÄÁÖÀÇ, Ç÷º½ÃÅ׸®¾ð ½Ä´ÜÀÇ ±ÞÁõ, Àå³» ¹Ì»ý¹° °Ç°­¿¡ ´ëÇÑ ¼ÒºñÀÚÀÇ ³ôÀº °ü½É°ú °ü·ÃÇÏ¿© °¡Àå ³ôÀº CAGRÀ» º¸ÀÏ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ÀÌ Áö¿ª¿¡´Â »õ·Î¿î ǰÁ¾°ú ¸ÀÀ» ºü¸£°Ô µµÀÔÇÏ´Â °íµµ·Î Çõ½ÅÀûÀÎ ½Äǰ ±â¼ú ºÎ¹®ÀÌ ÀÖ½À´Ï´Ù. °Ç°­À» °í·ÁÇÑ Áö¼Ó°¡´ÉÇÑ ½Ä¹°¼º Á¦Ç°¿¡ ÇÁ¸®¹Ì¾öÀ» ÁöºÒÇÏ·Á´Â ¼ÒºñÀÚÀÇ ³ôÀº ÀÇÁö°¡ ½ÃÀå ¼ºÀåÀ» °¡¼ÓÈ­ÇÒ °ÍÀÔ´Ï´Ù.

¹«·á Ä¿½ºÅ͸¶ÀÌ¡ ¼­ºñ½º:

ÀÌ º¸°í¼­¸¦ ±¸µ¶ÇÏ´Â °í°´Àº ´ÙÀ½°ú °°Àº ¹«·á ¸ÂÃãÈ­ ¿É¼Ç Áß Çϳª¸¦ ÀÌ¿ëÇÒ ¼ö ÀÖ½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå °³¿ä

Á¦2Àå ¼­¹®

Á¦3Àå ½ÃÀå µ¿Ç⠺м®

Á¦4Àå Porters Five Force ºÐ¼®

Á¦5Àå ¼¼°èÀÇ ÇÁ·Î¹ÙÀÌ¿Àƽ½º °­È­ À¯Á¦Ç° ´ëüǰ ½ÃÀå : Á¦Ç°º°

Á¦6Àå ¼¼°èÀÇ ÇÁ·Î¹ÙÀÌ¿Àƽ½º °­È­ À¯Á¦Ç° ´ëüǰ ½ÃÀå : ±ÕÁÖ À¯Çüº°

Á¦7Àå ¼¼°èÀÇ ÇÁ·Î¹ÙÀÌ¿Àƽ½º °­È­ À¯Á¦Ç° ´ëüǰ ½ÃÀå : °ø±Þ¿øº°

Á¦8Àå ¼¼°èÀÇ ÇÁ·Î¹ÙÀÌ¿Àƽ½º °­È­ À¯Á¦Ç° ´ëüǰ ½ÃÀå : ¿ëµµº°

Á¦9Àå ¼¼°èÀÇ ÇÁ·Î¹ÙÀÌ¿Àƽ½º °­È­ À¯Á¦Ç° ´ëüǰ ½ÃÀå : ÃÖÁ¾»ç¿ëÀÚº°

Á¦10Àå ¼¼°èÀÇ ÇÁ·Î¹ÙÀÌ¿Àƽ½º °­È­ À¯Á¦Ç° ´ëüǰ ½ÃÀå : Áö¿ªº°

Á¦11Àå ÁÖ¿ä ¹ßÀü

Á¦12Àå ±â¾÷ ÇÁ·ÎÆÄÀϸµ

KSA
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

According to Stratistics MRC, the Global Probiotic-Enriched Dairy Alternatives Market is accounted for $3.7 billion in 2025 and is expected to reach $7.9 billion by 2032 growing at a CAGR of 11.2% during the forecast period. Probiotic-enriched dairy alternatives are plant-based products like almond, soy, or oat milk, yogurt, or cheese infused with live probiotic cultures. These beneficial bacteria support gut health, digestion, and immunity. Designed for those avoiding dairy, these alternatives offer creamy textures and flavors while delivering health benefits. Available in beverages, yogurts, or spreads, they combine plant-based ingredients with probiotics, catering to consumers seeking vegan, lactose-free options for wellness and digestive support.

According to Mintel, plant-based yogurts and drinks are increasingly fortified with live cultures to support digestive health, merging the dairy-free and probiotic trends.

Market Dynamics:

Driver:

Demand for gut health

The primary driver is the surging consumer awareness of the gut microbiome's critical role in overall health, extending beyond digestion to immunity and mental well-being. This has created a proactive demand for functional foods that deliver proven benefits. Probiotic-enriched dairy alternatives perfectly merge this health trend with the parallel rise of plant-based diets, offering a dual benefit: they cater to lactose-intolerant, vegan, and flexitarian consumers while actively supporting their digestive wellness.

Restraint:

Regulatory hurdles for strains

A significant restraint is the complex and varying global regulatory landscape for probiotic strain claims. Health Canada, EFSA, and the FDA have stringent, differing requirements for substantiating specific health benefits like "supports immunity" or "improves digestive health." This creates costly and time-consuming barriers for manufacturers, limiting innovation and market entry. The inability to make explicit claims on packaging hinders consumer education and can stifle market growth, as shoppers may not understand the product's value proposition.

Opportunity:

Pet probiotics segment growth

A burgeoning opportunity exists in the pet probiotics segment, driven by the humanization of pets and owners' desire to extend wellness trends to their animals. Plant-based probiotic supplements and treats address growing concerns over pet food allergies, digestive issues, and overall animal wellness. This niche market is less saturated than human products and commands high premiumization potential, offering a lucrative avenue for expansion beyond the core consumer base into the lucrative pet care industry.

Threat:

Premium pricing slows adoption

A key market threat is the premium price point of these products, often significantly higher than conventional dairy or unenriched plant-based alternatives. This cost is due to expensive probiotic strains, complex fermentation processes, and quality certifications. For price-sensitive consumers, this premium can be a major barrier to trial and regular adoption, limiting the market to a health-conscious, higher-income demographic and slowing widespread mainstream acceptance and volume growth.

Covid-19 Impact:

The COVID-19 pandemic had a net positive impact, sharply accelerating demand. Intense consumer focus on bolstering immune health created a surge in interest for functional foods with proven benefits, directly benefiting probiotic products. While initial supply chain disruptions caused temporary shortages, the long-term effect was a permanent expansion of the consumer base. Many first-time buyers, seeking ways to enhance their wellness from home, tried and subsequently retained these products in their diets.

The plant-based yogurts segment is expected to be the largest during the forecast period

The plant-based yogurts segment is expected to account for the largest market share during the forecast period, resulting from its role as the most direct and popular probiotic carrier within the dairy-free category. It successfully mimics the texture, tanginess, and consumption experience of traditional dairy yogurt. Innovations in base ingredients like almond, oat, and coconut have improved taste and texture dramatically, making it the preferred choice for lactose-intolerant, vegan, and flexitarian consumers seeking gut health benefits.

The lactobacillus segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the lactobacillus segment is predicted to witness the highest growth rate, propelled by its well-documented and widely recognized health benefits, particularly for digestive health and immune support. It is one of the most researched and trusted probiotic genera among consumers. Manufacturers heavily favor lactobacillus strains for fermentation and enrichment due to their efficacy, stability, and familiarity, driving its rapid adoption in a wide array of new product formulations.

Region with largest share:

During the forecast period, the Asia Pacific region is expected to hold the largest market share, attributed to a high prevalence of lactose intolerance, a longstanding cultural tradition of consuming fermented plant-based foods (e.g., soy-based), and a massive consumer base. Growing disposable income, heightened health awareness post-pandemic, and the widespread availability of affordable local and international brands cement the region's leadership in this market.

Region with highest CAGR:

Over the forecast period, the North America region is anticipated to exhibit the highest CAGR associated with a surge in veganism, flexitarian diets, and a strong consumer focus on gut microbiome health. The region has a highly innovative food-tech sector that rapidly introduces new product varieties and flavors. High consumer willingness to pay a premium for health-forward, sustainable, and plant-based products accelerates market growth.

Key players in the market

Some of the key players in Probiotic-Enriched Dairy Alternatives Market include Chobani, Danone, Hain Celestial, Daiya Foods, Eden Foods, SunOpta, Melt Organic, Oatly, Blue Diamond Growers, Ripple Foods, Organic Valley, Living Harvest, Nestle, Mother Dairy, MilkyMist, Florastor, Yakult, and Amul Probiotic

Key Developments:

In Sep 2025, Amul launched its new "Amul Probiotic+"line of almond and oat milks, fortified with a unique synbiotic blend designed for gut health, marking its major entry into the value-added dairy alternative segment.

In Aug 2025, Oatly and Yakult announced a strategic partnership to co-develop a new range of ready-to-drink probiotic oat-based beverages, combining Oatly's base formulations with Yakult's proprietary Lactobacillus casei Shirota strain.

In July 2025, Danone introduced the next generation of its popular Silk Probiotic & Almond Milk, now featuring a 50% higher live and active cultures count at the time of consumption and an improved shelf-stable formulation for wider distribution.

Products Covered:

Strain Types Covered:

Sources Covered:

Applications Covered:

End Users Covered:

Regions Covered:

What our report offers:

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

Table of Contents

1 Executive Summary

2 Preface

3 Market Trend Analysis

4 Porters Five Force Analysis

5 Global Probiotic-Enriched Dairy Alternatives Market, By Product

6 Global Probiotic-Enriched Dairy Alternatives Market, By Strain Type

7 Global Probiotic-Enriched Dairy Alternatives Market, By Source

8 Global Probiotic-Enriched Dairy Alternatives Market, By Application

9 Global Probiotic-Enriched Dairy Alternatives Market, By End User

10 Global Probiotic-Enriched Dairy Alternatives Market, By Geography

11 Key Developments

12 Company Profiling

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â